COSMOS Pharmaceutical Corporation (3349.T)
JPY 6521.0
(-1.63%)
JPY 6521.0
(-1.63%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 31.5 Billion JPY | 4.56% |
| 2022 | 30.12 Billion JPY | 1.11% |
| 2021 | 29.79 Billion JPY | -10.11% |
| 2020 | 33.14 Billion JPY | 13.93% |
| 2019 | 29.09 Billion JPY | 17.43% |
| 2018 | 24.77 Billion JPY | 8.91% |
| 2017 | 22.74 Billion JPY | 2.3% |
| 2016 | 22.23 Billion JPY | 19.25% |
| 2015 | 18.64 Billion JPY | 9.18% |
| 2014 | 17.08 Billion JPY | 2.23% |
| 2013 | 16.7 Billion JPY | 7.59% |
| 2012 | 15.52 Billion JPY | 16.51% |
| 2011 | 13.32 Billion JPY | 32.76% |
| 2010 | 10.04 Billion JPY | 29.67% |
| 2009 | 7.74 Billion JPY | 42.36% |
| 2008 | 5.43 Billion JPY | 13.12% |
| 2007 | 4.8 Billion JPY | 27.77% |
| 2006 | 3.76 Billion JPY | 10.42% |
| 2005 | 3.4 Billion JPY | 50.86% |
| 2004 | 2.25 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 11.58 Billion JPY | 49.18% |
| 2023 Q1 | 8.99 Billion JPY | 12.93% |
| 2023 Q4 | 7.76 Billion JPY | -1.75% |
| 2023 Q3 | 7.9 Billion JPY | 15.41% |
| 2023 FY | 31.5 Billion JPY | 4.56% |
| 2023 Q2 | 6.84 Billion JPY | -23.85% |
| 2022 Q4 | 7.96 Billion JPY | 17.38% |
| 2022 FY | 30.12 Billion JPY | 1.11% |
| 2022 Q3 | 6.78 Billion JPY | 4.58% |
| 2022 Q2 | 6.48 Billion JPY | -27.13% |
| 2022 Q1 | 8.9 Billion JPY | 12.67% |
| 2021 Q1 | 8.55 Billion JPY | 19.88% |
| 2021 FY | 29.79 Billion JPY | -10.11% |
| 2021 Q3 | 6.91 Billion JPY | 7.71% |
| 2021 Q4 | 7.89 Billion JPY | 14.18% |
| 2021 Q2 | 6.42 Billion JPY | -24.93% |
| 2020 Q4 | 7.13 Billion JPY | -7.53% |
| 2020 FY | 33.14 Billion JPY | 13.93% |
| 2020 Q1 | 10.65 Billion JPY | 10.3% |
| 2020 Q2 | 7.63 Billion JPY | -28.32% |
| 2020 Q3 | 7.71 Billion JPY | 1.06% |
| 2019 Q2 | 4.94 Billion JPY | -29.63% |
| 2019 Q1 | 7.02 Billion JPY | 4.04% |
| 2019 FY | 29.09 Billion JPY | 17.43% |
| 2019 Q4 | 9.66 Billion JPY | 29.33% |
| 2019 Q3 | 7.46 Billion JPY | 51.13% |
| 2018 Q4 | 6.75 Billion JPY | 18.46% |
| 2018 Q3 | 5.69 Billion JPY | 6.86% |
| 2018 Q1 | 6.99 Billion JPY | 0.34% |
| 2018 FY | 24.77 Billion JPY | 8.91% |
| 2018 Q2 | 5.33 Billion JPY | -23.77% |
| 2017 Q4 | 6.97 Billion JPY | 27.07% |
| 2017 FY | 22.74 Billion JPY | 2.3% |
| 2017 Q3 | 5.48 Billion JPY | 35.99% |
| 2017 Q1 | 6.25 Billion JPY | 28.69% |
| 2017 Q2 | 4.03 Billion JPY | -35.54% |
| 2016 Q4 | 4.86 Billion JPY | -11.49% |
| 2016 FY | 22.23 Billion JPY | 19.25% |
| 2016 Q3 | 5.49 Billion JPY | 8.13% |
| 2016 Q2 | 5.08 Billion JPY | -25.27% |
| 2016 Q1 | 6.79 Billion JPY | 30.1% |
| 2015 Q4 | 5.22 Billion JPY | 22.36% |
| 2015 Q3 | 4.27 Billion JPY | 2.77% |
| 2015 Q2 | 4.15 Billion JPY | -16.8% |
| 2015 Q1 | 4.99 Billion JPY | 0.67% |
| 2015 FY | 18.64 Billion JPY | 9.18% |
| 2014 FY | 17.08 Billion JPY | 2.23% |
| 2014 Q2 | 4.26 Billion JPY | -2.15% |
| 2014 Q3 | 3.48 Billion JPY | -18.28% |
| 2014 Q4 | 4.96 Billion JPY | 42.26% |
| 2014 Q1 | 4.36 Billion JPY | 30.87% |
| 2013 Q4 | 3.33 Billion JPY | -15.56% |
| 2013 Q3 | 3.94 Billion JPY | -5.57% |
| 2013 Q2 | 4.18 Billion JPY | -20.34% |
| 2013 Q1 | 5.24 Billion JPY | 35.65% |
| 2013 FY | 16.7 Billion JPY | 7.59% |
| 2012 Q4 | 3.86 Billion JPY | 15.53% |
| 2012 FY | 15.52 Billion JPY | 16.51% |
| 2012 Q1 | 4.91 Billion JPY | 44.97% |
| 2012 Q2 | 3.4 Billion JPY | -30.8% |
| 2012 Q3 | 3.34 Billion JPY | -1.53% |
| 2011 FY | 13.32 Billion JPY | 32.76% |
| 2011 Q3 | 3.08 Billion JPY | 4.4% |
| 2011 Q2 | 2.95 Billion JPY | -24.23% |
| 2011 Q1 | 3.9 Billion JPY | 36.79% |
| 2011 Q4 | 3.38 Billion JPY | 9.85% |
| 2010 Q2 | 2.01 Billion JPY | -30.94% |
| 2010 Q1 | 2.92 Billion JPY | 18.93% |
| 2010 Q3 | 2.25 Billion JPY | 11.6% |
| 2010 Q4 | 2.85 Billion JPY | 26.6% |
| 2010 FY | 10.04 Billion JPY | 29.67% |
| 2009 Q4 | 2.45 Billion JPY | 78.82% |
| 2009 FY | 7.74 Billion JPY | 42.36% |
| 2009 Q3 | 1.37 Billion JPY | -36.83% |
| 2009 Q1 | 2.27 Billion JPY | 14.55% |
| 2009 Q2 | 2.17 Billion JPY | -4.4% |
| 2008 FY | 5.43 Billion JPY | 13.12% |
| 2008 Q2 | 1.06 Billion JPY | 0.0% |
| 2008 Q3 | 1.09 Billion JPY | 2.53% |
| 2008 Q4 | 1.98 Billion JPY | 81.54% |
| 2007 FY | 4.8 Billion JPY | 27.77% |
| 2006 FY | 3.76 Billion JPY | 10.42% |
| 2005 FY | 3.4 Billion JPY | 50.86% |
| 2004 FY | 2.25 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HEARTSEED INC | -1.45 Billion JPY | 2258.173% |
| Cawachi Limited | 7.6 Billion JPY | -314.432% |
| Pharmarise Holdings Corporation | 916 Million JPY | -3338.974% |
| Qol Holdings Co., Ltd. | 8.32 Billion JPY | -278.39% |
| MatsukiyoCocokara & Co. | 75.7 Billion JPY | 58.39% |
| Welcia Holdings Co., Ltd. | 43.23 Billion JPY | 27.133% |
| Create SD Holdings Co., Ltd. | 20.22 Billion JPY | -55.737% |
| NIHON CHOUZAI Co.,Ltd. | 9.14 Billion JPY | -244.499% |
| Tsuruha Holdings Inc. | 49.2 Billion JPY | 35.981% |
| Ohki Healthcare Holdings Co.,Ltd. | 2.04 Billion JPY | -1441.145% |
| Satudora Holdings Co.,Ltd. | 1.38 Billion JPY | -2174.44% |
| Kusuri No Aoki Holdings Co., Ltd. | 18.56 Billion JPY | -69.643% |
| Medical System Network Co., Ltd. | 3.83 Billion JPY | -722.051% |
| Shinnihonseiyaku Co., Ltd. | 3.75 Billion JPY | -739.132% |
| Sugi Holdings Co.,Ltd. | 36.62 Billion JPY | 13.986% |
| YAKUODO HOLDINGS Co., Ltd. | 5.21 Billion JPY | -504.51% |
| Astena Holdings Co., Ltd. | 1.12 Billion JPY | -2692.412% |
| Genky DrugStores Co., Ltd. | 9.01 Billion JPY | -249.39% |
| Ain Holdings Inc. | 20.43 Billion JPY | -54.175% |
| Sundrug Co.,Ltd. | 40.99 Billion JPY | 23.163% |